ROCHESTER, N.Y., Nov. 5, 2007 (PRIME NEWSWIRE) -- VirtualScopics, Inc. (NasdaqCM:VSCP - News), a leading developer of image-based biomarker solutions to the pharmaceutical, biotechnology and medical device industries, announced today that year-to-date 2007 contracted agreements total $8.4 million plus an additional $4.6 million in awarded agreements awaiting signature. The 2007 agreements-to-date include 10 of the top 15 pharmaceutical, biotechnology and medical device companies and represent 47 new contracts and 39 additions to the scope of existing contracts. Of the newly signed and awarded contracts, 24% are Phase III studies, 65% are Phase I/II studies and 11% are research studies.
